Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Net Preferred Shares Issued and Repurchased (2020 - 2021)

Updated

Context Therapeutics (CNTX) posted Net Preferred Shares Issued and Repurchased of $1.95 million for Q2 2021, down 35.8% from the prior quarter.

Analysis

Context Therapeutics (CNTX) Net Preferred Shares Issued and Repurchased (2020 - 2021) Analysis & Trends

For FY2020, Context Therapeutics' Net Preferred Shares Issued and Repurchased came in at $50,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -
9 Gsk 193.54 Bn 176.38 Bn - -
10 Context Therapeutics 15.24 Mn -182.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 1.95 Mn
Mar 31, 2021 3.03 Mn
Dec 31, 2020 350,000.00
API Access

Context Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=CNTX&period=max&api_key=YOUR_API_KEY